| To ensure that you never miss an issue, please whitelist us. |
|
|
| For patients with diabetes subsequently diagnosed and hospitalized with COVID-19, use of a sodium-glucose cotransporter-2 inhibitor (SGLT-2i) before COVID-19 infection is associated with lower COVID-19-related adverse outcomes, according to a systematic review and network meta-analysis published online Dec. 6 in JAMA Network Open. |
|
|
Individuals with type 2 diabetes face an increased risk for advanced tumor stage at cancer diagnosis, particularly for nonscreenable cancers, according to a study presented at the annual European Breast Cancer Conference. |
| |
| |
| Early-onset type 2 diabetes is an increasing global health problem for adolescents and young adults, according to a study published online Dec. 7 in The BMJ. |
| |
|
|
|